These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26221486)

  • 1. Receptor for advanced glycation end products involved in circulating endothelial cells release from human coronary endothelial cells induced by C-reactive protein.
    Zhou S; Gao L; Gong F; Chen X
    Iran J Basic Med Sci; 2015 Jun; 18(6):610-5. PubMed ID: 26221486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein stimulates RAGE expression in human coronary artery endothelial cells in vitro via ROS generation and ERK/NF-κB activation.
    Zhong Y; Cheng CF; Luo YZ; Tian CW; Yang H; Liu BR; Chen MS; Chen YF; Liu SM
    Acta Pharmacol Sin; 2015 Apr; 36(4):440-7. PubMed ID: 25832424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of receptor for advanced glycation end products (RAGE) on the surface of circulating endothelial cells is upregulated in Kawasaki disease.
    Gong F; Zhang Y; Xie C; Zhu W; Wang W; Fu S; Shen H
    Pediatr Res; 2012 Jun; 71(6):720-4. PubMed ID: 22337222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocyte-Derived Interleukin-1β As the Driver of S100A12-Induced Sterile Inflammatory Activation of Human Coronary Artery Endothelial Cells: Implications for the Pathogenesis of Kawasaki Disease.
    Armaroli G; Verweyen E; Pretzer C; Kessel K; Hirono K; Ichida F; Okabe M; Cabral DA; Foell D; Brown KL; Kessel C
    Arthritis Rheumatol; 2019 May; 71(5):792-804. PubMed ID: 30447136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein induces release of both endothelial microparticles and circulating endothelial cells in vitro and in vivo: further evidence of endothelial dysfunction.
    Devaraj S; Kumaresan PR; Jialal I
    Clin Chem; 2011 Dec; 57(12):1757-61. PubMed ID: 21980169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-Reactive protein upregulates receptor for advanced glycation end products expression in human endothelial cells.
    Zhong Y; Li SH; Liu SM; Szmitko PE; He XQ; Fedak PW; Verma S
    Hypertension; 2006 Sep; 48(3):504-11. PubMed ID: 16847147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein upregulates receptor for advanced glycation end products expression and alters antioxidant defenses in rat endothelial progenitor cells.
    Chen J; Huang L; Song M; Yu S; Gao P; Jing J
    J Cardiovasc Pharmacol; 2009 May; 53(5):359-67. PubMed ID: 19276989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein down-regulates endothelial nitric oxide synthase expression and promotes apoptosis in endothelial progenitor cells through receptor for advanced glycation end-products.
    Chen J; Jin J; Song M; Dong H; Zhao G; Huang L
    Gene; 2012 Apr; 496(2):128-35. PubMed ID: 22301267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100A12 on circulating endothelial cells surface in children with Kawasaki disease.
    Fu S; Gong F; Xie C; Zhu W; Wang W; Shen H; Tang Y
    Pediatr Res; 2010 Aug; 68(2):165-8. PubMed ID: 20461025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein (CRP) up-regulates expression of receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in THP-1 cells: inhibitory effects of atorvastatin.
    Mahajan N; Bahl A; Dhawan V
    Int J Cardiol; 2010 Jul; 142(3):273-8. PubMed ID: 19201044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced glycation end-products decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells.
    Ren X; Ren L; Wei Q; Shao H; Chen L; Liu N
    Cardiovasc Diabetol; 2017 Apr; 16(1):52. PubMed ID: 28427390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between Advanced Glycation End Products, Soluble RAGE Receptor, and Endothelium Dysfunction, Evaluated by Circulating Endothelial Cells and Endothelial Progenitor Cells in Patients with Mild and Resistant Hypertension.
    Gryszczyńska B; Budzyń M; Begier-Krasińska B; Osińska A; Boruczkowski M; Kaczmarek M; Bukowska A; Iskra M; Kasprzak MP
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and function of receptors for advanced glycation end products in bovine corneal endothelial cells.
    Kaji Y; Amano S; Usui T; Oshika T; Yamashiro K; Ishida S; Suzuki K; Tanaka S; Adamis AP; Nagai R; Horiuchi S
    Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):521-8. PubMed ID: 12556378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mdia1 is Crucial for Advanced Glycation End Product-Induced Endothelial Hyperpermeability.
    Zhou X; Weng J; Xu J; Xu Q; Wang W; Zhang W; Huang Q; Guo X
    Cell Physiol Biochem; 2018; 45(4):1717-1730. PubMed ID: 29490301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic levels of the anti-inflammatory decoy receptor soluble RAGE (receptor for advanced glycation end products) are decreased in dogs with inflammatory bowel disease.
    Heilmann RM; Otoni CC; Jergens AE; Grützner N; Suchodolski JS; Steiner JM
    Vet Immunol Immunopathol; 2014 Oct; 161(3-4):184-92. PubMed ID: 25183017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in non-diabetic subjects with pre-mature coronary artery disease.
    Mahajan N; Malik N; Bahl A; Dhawan V
    Atherosclerosis; 2009 Dec; 207(2):597-602. PubMed ID: 19576587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble RAGE and the RAGE ligands HMGB1 and S100A12 in critical illness: impact of glycemic control with insulin and relation with clinical outcome.
    Ingels C; Derese I; Wouters PJ; Van den Berghe G; Vanhorebeek I
    Shock; 2015 Feb; 43(2):109-16. PubMed ID: 25394242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of the receptor for advanced glycation-end products (RAGE) in beta-amyloid-induced toxic effects in rat cerebromicrovascular endothelial cells cultured in vitro.
    Baiguera S; Fioravanzo L; Grandi C; Di Liddo R; Parnigotto PP; Folin M
    Int J Mol Med; 2009 Jul; 24(1):9-15. PubMed ID: 19513528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The receptor for advanced glycation end products (RAGE) system in women with intraamniotic infection and inflammation.
    Buhimschi IA; Zhao G; Pettker CM; Bahtiyar MO; Magloire LK; Thung S; Fairchild T; Buhimschi CS
    Am J Obstet Gynecol; 2007 Feb; 196(2):181.e1-13. PubMed ID: 17306673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fructose causes endothelial cell damage via activation of advanced glycation end products-receptor system.
    Sotokawauchi A; Matsui T; Higashimoto Y; Yamagishi SI
    Diab Vasc Dis Res; 2019 Nov; 16(6):556-561. PubMed ID: 31375034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.